Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Geron Corporation - Common Stock
(NQ:
GERN
)
1.800
-0.080 (-4.26%)
Streaming Delayed Price
Updated: 10:10 AM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,083,747
Open
1.840
Bid (Size)
1.800 (9,600)
Ask (Size)
1.810 (12,900)
Prev. Close
1.880
Today's Range
1.790 - 1.900
52wk Range
1.040 - 2.576
Shares Outstanding
508,766,846
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates
↗
November 05, 2025
Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction.
Via
Chartmill
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 05, 2025
From
Geron Corporation
Via
Business Wire
Performance
YTD
+36.4%
+36.4%
1 Month
+30.4%
+30.4%
3 Month
+55.2%
+55.2%
6 Month
+26.8%
+26.8%
1 Year
-24.7%
-24.7%
More News
Read More
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Geron Earnings Preview
↗
November 04, 2025
Via
Benzinga
Geron Corporation to Present at Upcoming Investor Conferences
November 04, 2025
From
Geron Corporation
Via
Business Wire
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
November 03, 2025
From
Geron Corporation
Via
Business Wire
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
October 27, 2025
From
Geron Corporation
Via
Business Wire
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 23, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2025
From
Geron Corporation
Via
Business Wire
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
August 27, 2025
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2025
From
Geron Corporation
Via
Business Wire
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 13, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From
Geron Corporation
Via
Business Wire
Geron (GERN) Q2 Revenue Jumps 5,477%
↗
August 06, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 06, 2025
Via
Benzinga
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 06, 2025
From
Geron Corporation
Via
Business Wire
Geron Appoints Harout Semerjian as President and Chief Executive Officer
August 06, 2025
From
Geron Corporation
Via
Business Wire
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025
July 28, 2025
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2025
From
Geron Corporation
Via
Business Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
May 28, 2025
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2025
From
Geron Corporation
Via
Business Wire
GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron
May 12, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Frequently Asked Questions
Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.800
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 02/23/26 10:10 AM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 915.78M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 916M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
